Latest Share Chat

REMOVE ADS

Hemogenyx Pharmaceuticals Share News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

794.00 -35.50 (-4.44%)

Bid:

735.00

Ask:

794.00

Spread: 59.00 (8.027%)

Market Cap: £53.99m

Last checked at -

Intraday Hemogenyx Pharmaceuticals Share Chart

REMOVE ADS

Hemogenyx Pharmaceuticals News

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Hemogenyx says exploring commercialisation of treatment for leukaemia

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell ...

Hemogenyx shares jump as third patient treated for leukaemia form

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial...

Hemogenyx inks manufacturing partnership deal with Made Scientific

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract developme...

Hemogenyx stock rises on GBP570,000 fundraise for Chimeric trials

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it has raised funds to continue phase 1 clinical trials, through an off-market allotme...

Hemogenyx Pharmaceuticals shares up as phase one trial progresses

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said a third patient has been successfully treated under its phase one trial of its CAR-T ce...

SMALL-CAP WINNERS & LOSERS: Card Factory buys WH Smith's funkypigeon

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

TRADING UPDATES: Journeo, Physiomics and Synectics win contracts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday and not separately reported by Al...